Howard Trachtman, MD
Adjunct Clinical Professor of Pediatrics
University of Michigan
Howard Trachtman, M.D., has worked as a pediatric nephrologist for decades and is an adjunct clinical professor of pediatrics at the University of Michigan Medical School. Dr. Trachtman is highly regarded for his clinical research and treatment of glomerular diseases in children, such as Focal Segmental Glomerulosclerosis (FSGS) and Nephrotic Syndrome. Formally, Dr. Trachtman was a Professor of Clinical Pediatrics and Chief of the Division of Pediatric Nephrology at NYU Grossman School of Medicine and NYU Langone Health from December 2011 until June 2021.
Presenting Modules:
Clinical Approach and Emerging Therapeutics for FSGS
Focal Segmental Glomerulosclerosis (FSGS) is a rare but significant disease that has caused clinical confusion for decades. Fortunately, the past decade has yielded monumental progress in our understanding of its underlying mechanisms. With the landmark April 2026 FDA approval of sparsentan—the very first drug indicated specifically for FSGS—there has never been a more critical or perfect time for this course.
Because managing this evolving landscape requires seamless collaboration, this module specifically focuses on an interprofessional team approach to treating FSGS, leveraging the distinct and overlapping expertise of nephrologists and clinical pharmacists to optimize patient outcomes.